Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology | Family Medicine
Disease Category: Gout (Hyperuricemia)
Location: United States, OK

Clinical Trial Details

Overview

Research Study Summary

Do you suffer from gout?

Purpose

Objective of the study is to assess the efficacy and safety of Febuxostat 40 mg QD and Febuxostat 80 mg QD, compared to Allopurinol in subjects with hyperuricemia and gout. The study's duration is 6 months long.

Patient Inclusion Criteria

  • Male or female (18 to 85 years of age)
  • History or presence of gout

Patient Exclusion Criteria

  • Received ULT within 30 days of randomizing
  • History of cancer, other than basal cell, within 5 years
  • Rheumatoid arthritis requiring treatment

For more information,

To Learn more
Gender

Both Male and Female

Age

18 to 85 Years

Overall Status

Recruiting

Facility Type

N/A

Contact

Health Research Institute
1044 SW 44th Street
Suite 403
Oklahoma City, OK 73109
Phone: 405-616-4888
Fax: 405-616-4885

View Map

Research Center Information: Health Research Institute

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 109331

Date Last Changed: July 25, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.